15-71811481-A-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014249.4(NR2E3):c.119-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000257 in 1,554,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_014249.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 37Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Goldmann-Favre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014249.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | NM_014249.4 | MANE Select | c.119-2A>G | splice_acceptor intron | N/A | NP_055064.1 | |||
| NR2E3 | NM_016346.4 | c.119-2A>G | splice_acceptor intron | N/A | NP_057430.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | ENST00000617575.5 | TSL:1 MANE Select | c.119-2A>G | splice_acceptor intron | N/A | ENSP00000482504.1 | |||
| NR2E3 | ENST00000621098.1 | TSL:1 | c.119-2A>G | splice_acceptor intron | N/A | ENSP00000479962.1 | |||
| NR2E3 | ENST00000621736.4 | TSL:2 | c.-146-2A>G | splice_acceptor intron | N/A | ENSP00000479254.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152002Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000214 AC: 3AN: 1402938Hom.: 0 Cov.: 33 AF XY: 0.00000144 AC XY: 1AN XY: 692406 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152002Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74252 show subpopulations
ClinVar
Submissions by phenotype
Enhanced S-cone syndrome Pathogenic:2
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 18294254). ClinVar contains an entry for this variant (Variation ID: 1361677). Disruption of this splice site has been observed in individual(s) with autosomal recessive enhanced S-cone syndrome (PMID: 10655056, 24474277, 25079116). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 1 of the NR2E3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NR2E3 are known to be pathogenic (PMID: 15459973, 27522502).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at